Novel insights into the delayed vasospasm following subarachnoid haemorrhage: Importance of proteinase signalling

British Journal of Pharmacology

Volumn 165, Issue 1, 2012, Pages 103-105

  Hollenberg, Morley D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

anticoagulant thrombolytic drugs; antioxidants NO pathways drugs; cardiovascular pharmacology; coagulation fibrinolysis; control of smooth muscle; drug receptor mechanisms; endothelin; GPCRs; inflammation; molecular pharmacology

Indexed keywords

ANTIOXIDANT; ARGATROBAN; ASCORBIC ACID; CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN A RECEPTOR ANTAGONIST; NAFAMSTAT MESILATE; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 1; TEMPOL; THROMBIN; THROMBIN INHIBITOR; THROMBIN RECEPTOR; VASODILATOR AGENT;

BRAIN VASOSPASM; DRUG EFFICACY; DRUG TARGETING; HUMAN; NERVE DEGENERATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTION;

ANIMALS; ANTIOXIDANTS; MALE; PIPECOLIC ACIDS; SUBARACHNOID HEMORRHAGE; THROMBIN; VASOCONSTRICTION;

EID: 82955173712     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01564.x     Document Type: Review

References (16)

1. Adams MN, Ramachandran R, Yau MK, Suen JY, Fairlie DP, Hollenberg MD, et al,. (2011). Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 130: 248-282.
2. Coughlin SR, (2005). Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3: 1800-1814. (Pubitemid 41716567)
3. Ecker A, Riemenschneider PA, (1951). Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms. J Neurosurg 8: 660-667.
4. Hirano K, Hirano M, (2010). Current perspective on the role of the thrombin receptor in cerebral vasospasm after subarachnoid hemorrhage. J Pharmacol 114: 127-133.
5. Hollenberg MD, Compton SJ, (2002). International union of pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol Rev 54: 203-217. (Pubitemid 34575710)
6. Kameda K, Kikkawa Y, Hirano M, Matsuo S, Sasaki T, Hirano K, (2011). Combined argatroban and anti-oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid hemorrhage. Br J Pharmacol 165: 106-119.
7. Kolias AG, Sen J, Belli A, (2009). Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res 87: 1-11.
8. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al,. (2011). Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10: 618-625.
9. Noorbakhsh F, Vergnolle N, Hollenberg MD, Power C, (2003). Proteinase-activated receptors in the nervous system. Nat Rev Neurosci 4: 981-990. (Pubitemid 37486674)
10. Oikonomopoulou K, Hansen KK, Saifeddine M, Tea I, Blaber M, Blaber SI, et al,. (2006). Proteinase-activated receptors, targets for kallikrein signaling. J Biol Chem 281: 32095-32112. (Pubitemid 46036764)
11. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, et al,. (2009). Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 31: 151-158.
12. Ramachandran R, Hollenberg MD, (2008). Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 153 (Suppl. 1): S263-S282. (Pubitemid 351340983)
13. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, et al,. (2005). Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103: 9-17. (Pubitemid 43193928)
14. Weir B, Grace M, Hansen J, Rothberg C, (1978). Time course of vasospasm in man. J Neurosurg 48: 173-178. (Pubitemid 8269962)
15. Weir B, Macdonald RL, Stoodley M, (1999). Etiology of cerebral vasospasm. Acta Neurochir Suppl 72: 27-46.
16. Yanamoto H, Kikuchi H, Sato M, Shimizu Y, Yoneda S, Okamoto S, (1992). Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage. Neurosurgery 30: 358-363.